Delcath Systems (NSDQ:DCTH) proposed offering up to $5 million in units and $5 million in pre-funded units this week to fund the company’s clinical and commercial operations.
The New York-based company plans to offer 500,000,000 units made up of Series C units with one share of common stock and Series E warrants to buy one share of common stock. Delcath also said it would offer up to 500,000,000 Series D units made up of pre-funded warrants to buy one share of common stock and Series E warrants to purchase one share of common stock.
Get the full story at our sister site, Drug Delivery Business News.
The post Delcath registers $10m offering appeared first on MassDevice.